Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Halozyme
Biotech
Baynes ditches Merck for CMO role at Eikon—Chutes and Ladders
Baynes to be new CMO at Eikon, following Perlmutter. Ex-Biogen R&D chief embarks on new voyage. Former FDA deputy director joins Mesoblast board.
Max Bayer
Mar 25, 2022 9:30am
Life after R&D death: Halozyme's pivot and path to profitability
Aug 10, 2020 4:01pm
BIO's first breakdown of diversity: 'We can do better'
Jan 31, 2020 9:55am
Halozyme cuts pipeline, 55% of jobs as lead cancer med flops
Nov 4, 2019 9:56am
CEOs weigh in on biotechs going public earlier and earlier
Jun 12, 2019 11:03am
BIO: In conversation with Helen Torley, CEO of Halozyme
Jun 7, 2019 9:58am
